熱點掃描 | 稀土有色漲幅靠前,生物技術板塊內分化嚴重
uSMART盈立智投1月11日消息,截止發稿,港股三大指數齊漲,恆生指數上漲0.08%,報23765.39點,成交額546.56億;恆生科技指上漲0.02%,報5626.46點,成交額92.28億;紅籌指數上漲0.78%報4106.01點,成交額24.65億。三指開盤微微走弱後快速回漲。
盤面上來看,稀土有色股漲幅靠前,五礦資源漲超5%、中國鋁業漲4.63%、馬鞍山鋼鐵漲3.48%;
綠電概念走高,華潤電力漲超6%、大唐發電漲4.52%、大唐新能源漲4.76%;
生物技術板塊分化,再鼎醫藥漲6.52%、藥明生物漲5.26%;康希諾生物跌6.24%、永泰生物跌26.20%。
熱門個股:
騰訊控股漲1.28%,報458.8港元;
廣發證券跌0.22%,報22.25港元;
龍湖集團漲2.33%,報41.8港元;
中國通商集團漲1.85%,報1.1港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.